DEXCOM, INC.
DXCM US2521311074
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
Annual Performance 1
2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
50% | -13% | 8% | -37% | 3% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Malady Kyle |
80.86 USD |
667 Sold |
53,934 USD |
05/09/2025 | 05/09/2025 |
Stern Sadie EX VP |
80.00 USD |
1,466 Sold |
117,280 USD |
04/09/2025 | 04/09/2025 |
Sylvain Jereme M EX VP |
74.17 USD |
4,824 Sold |
357,796 USD |
02/09/2025 | 02/09/2025 |
Brown Michael Jon EX VP |
80.29 USD |
500 Sold |
40,145 USD |
15/08/2025 | 15/08/2025 |
Foletta Mark G |
81.54 USD |
195 Sold |
15,900 USD |
15/08/2025 | 15/08/2025 |
Foletta Mark G |
81.02 USD |
2,555 Sold |
207,003 USD |
15/08/2025 | 15/08/2025 |
Stern Sadie EX VP |
88.99 USD |
1,466 Sold |
130,459 USD |
28/07/2025 | 28/07/2025 |
Foletta Mark G |
85.17 USD |
2,742 Sold |
233,528 USD |
15/07/2025 | 15/07/2025 |
Foletta Mark G |
86.03 USD |
8 Sold |
688 USD |
15/07/2025 | 15/07/2025 |
Brown Michael Jon EX VP |
86.03 USD |
500 Sold |
43,015 USD |
15/07/2025 | 15/07/2025 |